Immunological studies before and during interferon therapy in chronic HBV infection: Identification of factors predicting response

✍ Scribed by Dr. Linda J. Scully; David Brown; Chris Lloyd; Ruvan Shein; Professor Howard C. Thomas

• Book ID: 102849760
• Publisher: John Wiley and Sons
• Year: 1990
• Tongue: English
• Weight: 685 KB
• Volume: 12
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1002/hep.1840120506

✦ Synopsis

Lymphoblastoid interferon is effective therapy in some but not all patients with chronic hepatitis B virus infection. To asseas whether immunological parameters were predictive of response to interferon therapy, we determined the human leukocyte antigen type, CD4/CD8 ratio, natural killer cell activity, IgM anti-HBc antibody levels and concanavalin A-induced lymphocyte proliferative response in 30 patients before treatment. In addition, to investigate the mechanisms of action of interferon in promoting hepatitis B virus clearance, we serially measured the CD4/CD8 ratios, natural killer activity and lymphocyte proliferative response at wk 4, 8 and 12 of treatment. A beneficial response to therapy was defined as the sustained clearance of HBeAg and serum hepatitis B virus DNA within 1 yr of commencing therapy. Elevated IgM anti-HBc levels were associated with a beneficial response to therapy, but there was no correlation observed between response and pretreatment CD4/CD8 ratio, natural killer activity or lymphocyte proliferative response. Six of seven human leukocyte antigen DR3-poeitive patients responded. No measurable changes in the immunological parameters studied were observed in the nonresponder group, whereas a signiiicant rise in CD4/CD8 ratio, associated with a fall in peripheral CD8 number and a decline in measurable NK activity, was seen in the responder group. These changes were maximal at the time of hepatitis B virus DNA clearance, which was associated with a transient increase in hepatic inflammation. Whether these changes occurred because of hepatic sequestration of cytotoxic and natural killer cells in the liver at the time of seroconversion or reflected an interferon-induced altered immunoregulatory balance requires further investigation. (IIEPATOLOCY 1990;12:1111-1117.)